Fredrik Hellborg is a molecular biologist from Stockholm University with a doctoral thesis at Karolinska Institutet in experimental tumor biology. He has solid experience in sales and development within Life Sciences. He previously worked in sales at VWR, a large distributor of lab materials, helped build Pico Vitro's sales channels and worked in business development at Sophia Genetics, a company in sequence data analysis.

"Fredrik Hellborg will contribute to our increasing sales, partly through his network, partly through his experience in meeting the lab's needs in the field of cancer diagnostics – understanding what is in demand and how we best meet this," says Carl-Johan Ivarsson, Qlucore's CEO.

"Qlucore ensures that the research benefits the patients. This is where I want to be involved and contribute. What attracted me is that Qlucore provides the ability to interpret and visualize such large amounts of data, and that it is also done with a focus on analysts and treating doctors, says Fredrik Hellborg. He continues:

"There is huge potential in Qlucore. The fact that the software is modular is a strength, and the fact that Qlucore focused at an early stage on approval according to IVDR, the new regulatory framework for diagnostics, means that they have a big advantage once this potential is realized".